For more than 20 years, the Stem Cell Network has made strategic investments in stem cell and regenerative medicine research, helping to position Canada as a global leader in the field. As Canada’s on...

If you live with type 1 diabetes (T1D), or love someone who does, you know how much daily effort it takes to stay healthy and how urgently better treatments and cures are needed. That’s why we want to share an important update. Breakthrough T1D Canada has formally asked the federal government to partner with us […]

JDRF Clinician Investigator Fellowships are designed to attract and promote clinician scientists in the field of T1D research. These fellowships are open to medical residents who are pursuing graduate...

Find a career with Breakthrough T1D

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimisle...

A clinical trial involving adolescents with type 1 diabetes (T1D) has found a combination therapy may reduce chronic kidney disease and improve health outcomes. The findings could help guide more prec...

Explore Breakthrough T1D’s funding opportunities for type 1 diabetes research. Learn how we support innovative projects driving breakthroughs in T1D treatment, prevention, and cures.

The Canadian Population Screening for Risk of Type 1 Diabetes (CanScreen T1D) research consortium aims to launch a pilot screening program for children in Canada. The consortium studies the accessibility and feasibility of a T1D screening program through different research projects, ensuring equity, diversity, and inclusion measures in the program design.

On May 5, 2025, Sanofi announced Health Canada approval of Tzield, the first disease-modifying therapy for type 1 diabetes (T1D). This is a huge win for the T1D community in that it is the first medic...

Explore Breakthrough T1D’s funding opportunities for type 1 diabetes research. Learn how we support innovative projects driving breakthroughs in T1D treatment, prevention, and cures.

Assistant Professor (tenure track) - Chromatin Regulation, Genetic Regulatory Mechanisms, Epigenetics, Epigenomics

Costs & Coverage Please note that most mental health providers typically charge a fee on a per visit basis. If you have private insurance, it may cover specific mental health services. We recommend ch...

On March 27, 2025 Diabetes Canada released updated Clinical Practice Guidelines for the glycemic management across the lifespan for people with type 1 diabetes. What are clinical practice guidelines a...

What's up with IA2A?! Excited to share this collaborative work in Diabetologia showing that IA-2A+ is consistently linked to increased disease progression…

CanScreen T1D Research Consortium Creating Canada's First Type 1 Diabetes Screening Program Learn about what we do CanScreen T1D Research Consortium Your child’s health matters. The Canadi...